Your browser doesn't support javascript.
loading
An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review.
Xia, Eric; Li, Sara J; Drake, Lara; Reyes-Hadsall, Sophia; Mita, Carol; Drucker, Aaron M; Mostaghimi, Arash.
Affiliation
  • Xia E; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Chobanian & Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA.
  • Li SJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Drake L; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Reyes-Hadsall S; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Mita C; Countway Library, Harvard Medical School, Boston, Massachusetts, USA.
  • Drucker AM; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
  • Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: amostaghimi@bwh.harvard.edu.
J Invest Dermatol ; 143(7): 1133-1137.e12, 2023 07.
Article in En | MEDLINE | ID: mdl-37115113
ABSTRACT
Although progress has been made in developing outcome measures for AA, the use of these measures remains unstandardized. A scoping review was conducted to identify the clinician-reported outcome measures (ClinROMs) and patient-reported outcome measures (PROMs) used in assessing and treating AA, the results of which revealed heterogeneity in AA outcome measures. Of 23 research studies ultimately included, only 2 ClinROMs were used by >15% of studies; likewise, of 110 clinical trials evaluated, numerous outcome instruments were used, but only one ClinROM was used by >5% of trials (Severity of Alopecia Tool). These results suggest the need for consensus and standardization in both research and trial settings.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alopecia Areata Type of study: Diagnostic_studies / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: J Invest Dermatol Year: 2023 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alopecia Areata Type of study: Diagnostic_studies / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: J Invest Dermatol Year: 2023 Document type: Article Affiliation country: United States